Cite

    Ziyi Yang et al.. “Inhibition of stromal‐interacting molecule 1‐mediated store‐operated Ca2+ entry as a novel strategy for the treatment of acquired imatinib‐resistant gastrointestinal stromal tumors.” Cancer science, vol. 109, no. 9, 2018, pp. 2792–2800. http://access.bl.uk/ark:/81055/vdc_100068607350.0x000024